Nonsteroidal anti-inflammatory drugs after acute myocardial infarction

This publication has 15 references indexed in Scilit:

• C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy
  Journal of the American College of Cardiology, 1998
• Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
  New England Journal of Medicine, 1997
• The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
  New England Journal of Medicine, 1994
• Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.
  Circulation, 1994
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Leukocyte Count and Risk of Major Coronary Heart Disease Events
  American Journal of Epidemiology, 1992
• Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)
  The American Journal of Cardiology, 1990
• Role of a nonsteroidal anti-inflammatory agent, ibuprofen, in coronary revascularization after acute myocardial infarction
  Basic Research in Cardiology, 1990
• Delayed effects of early infarct-limiting therapies on healing after myocardial infarction.
  Circulation, 1985
• The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction.
  Circulation, 1982